Cargando…

Structural Features Affecting the Interactions and Transportability of LAT1-Targeted Phenylalanine Drug Conjugates

[Image: see text] L-type amino acid transporter 1 (LAT1) transfers essential amino acids across cell membranes. Owing to its predominant expression in the blood–brain barrier and tumor cells, LAT1 has been exploited for drug delivery and targeting to the central nervous system (CNS) and various canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bahrami, Katayun, Järvinen, Juulia, Laitinen, Tuomo, Reinisalo, Mika, Honkakoski, Paavo, Poso, Antti, Huttunen, Kristiina M., Rautio, Jarkko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811466/ https://www.ncbi.nlm.nih.gov/pubmed/36394563 http://dx.doi.org/10.1021/acs.molpharmaceut.2c00594

Ejemplares similares

Development of Sesamol Carbamate-L-Phenylalanine Prodrug Targeting L-Type Amino Acid Transporter1 (LAT1) as a Potential Antiproliferative Agent against Melanoma
por: Srisongkram, Tarapong, et al.
Publicado: (2022)

Tyrosine–Chlorambucil Conjugates Facilitate Cellular Uptake through L-Type Amino Acid Transporter 1 (LAT1) in Human Breast Cancer Cell Line MCF-7
por: Pocasap, Piman, et al.
Publicado: (2020)

Regulation of the human tyrosinase gene in retinal pigment epithelium cells: the significance of transcription factor orthodenticle homeobox 2 and its polymorphic binding site
por: Reinisalo, Mika, et al.
Publicado: (2012)

Role of L-Type Amino Acid Transporter 1 (LAT1) for the Selective Cytotoxicity of Sesamol in Human Melanoma Cells
por: Srisongkram, Tarapong, et al.
Publicado: (2019)

Sodium-Dependent Neutral Amino Acid Transporter 2 Can Serve as a Tertiary Carrier for l-Type Amino Acid Transporter 1-Utilizing Prodrugs
por: Huttunen, Johanna, et al.
Publicado: (2023)

l-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia
por: Huttunen, Johanna, et al.
Publicado: (2019)

Comparison of Experimental Strategies to Study l-Type Amino Acid Transporter 1 (LAT1) Utilization by Ligands
por: Huttunen, Johanna, et al.
Publicado: (2021)

Comparative Modelling of Organic Anion Transporting Polypeptides: Structural Insights and Comparison of Binding Modes
por: Tonduru, Arun Kumar, et al.
Publicado: (2022)

Structural Characterization of LsrK as a Quorum Sensing Target and a Comparison between X-ray and Homology Models
por: Medarametla, Prasanthi, et al.
Publicado: (2021)

Targeting Glial Cells by Organic Anion-Transporting Polypeptide 1C1 (OATP1C1)-Utilizing l-Thyroxine-Derived Prodrugs
por: Tonduru, Arun Kumar, et al.
Publicado: (2023)

Neurosteroids: Structure-Uptake Relationships and Computational Modeling of Organic Anion Transporting Polypeptides (OATP)1A2
por: Adla, Santosh Kumar, et al.
Publicado: (2021)

Hemocompatible LAT1-inhibitor can induce apoptosis in cancer cells without affecting brain amino acid homeostasis
por: Markowicz-Piasecka, Magdalena, et al.
Publicado: (2020)

Assessment of mutation probabilities of KRAS G12 missense mutants and their long-timescale dynamics by atomistic molecular simulations and Markov state modeling
por: Pantsar, Tatu, et al.
Publicado: (2018)

Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors
por: Zięba, Agata, et al.
Publicado: (2021)

Aminopeptidase B can bioconvert L-type amino acid transporter 1 (LAT1)-utilizing amide prodrugs in the brain
por: Hugele, Agathe, et al.
Publicado: (2022)

New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma
por: Verhoeven, Jeroen, et al.
Publicado: (2019)

Sweet Battle of the Epimers—Continued Exploration of Monosaccharide-Derived Delivery Agents for Boron Neutron Capture Therapy
por: Matović, Jelena, et al.
Publicado: (2023)

In Vitro and In Silico Evaluation of Bikaverin as a Potent Inhibitor of Human Protein Kinase CK2
por: Haidar, Samer, et al.
Publicado: (2019)

Addressing the Biochemical Foundations of a Glucose-Based “Trojan Horse”-Strategy to Boron Neutron Capture Therapy: From Chemical Synthesis to In Vitro Assessment
por: Matović, Jelena, et al.
Publicado: (2020)

Synthesis and In Vitro Evaluation of a Set of 6-Deoxy-6-thio-carboranyl d-Glucoconjugates Shed Light on the Substrate Specificity of the GLUT1 Transporter
por: Matović, Jelena, et al.
Publicado: (2022)

Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining
por: Haidar, Samer, et al.
Publicado: (2017)

In Vitro Identification and In Vivo Confirmation of Inhibitors for Sweet Potato Chlorotic Stunt Virus RNA Silencing Suppressor, a Viral RNase III
por: Wang, Linping, et al.
Publicado: (2021)

Antimicrobial and Antifungal Activity of Rare Substituted 1,2,3-Thiaselenazoles and Corresponding Matched Pair 1,2,3-Dithiazoles
por: Laitinen, Tuomo, et al.
Publicado: (2020)

Metabolism-Disrupting Chemicals and the Constitutive Androstane Receptor CAR
por: Küblbeck, Jenni, et al.
Publicado: (2020)

A Prospective Follow-up Study of Fingertip Amputation Treatment With Semi-occlusive Dressing
por: Rautio, Sanni, et al.
Publicado: (2023)

Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021)

The EDCMET Project: Metabolic Effects of Endocrine Disruptors
por: Küblbeck, Jenni, et al.
Publicado: (2020)

Rush Hour of LATs towards Their Transport Cycle
por: Nicolàs-Aragó, Adrià, et al.
Publicado: (2021)

The rs113883650 variant of SLC7A5 (LAT1) gene may alter brain phenylalanine content in PKU
por: Bik-Multanowski, Miroslaw, et al.
Publicado: (2021)

A novel differentiated HuH-7 cell model to examine bile acid metabolism, transport and cholestatic hepatotoxicity
por: Saran, Chitra, et al.
Publicado: (2022)

Comparative molecular field analysis and molecular dynamics studies of α/β hydrolase domain containing 6 (ABHD6) inhibitors
por: Kaczor, Agnieszka A., et al.
Publicado: (2015)

LAT1 and SNAT2 Protein Expression and Membrane Localization of LAT1 Are Not Acutely Altered by Dietary Amino Acids or Resistance Exercise Nor Positively Associated with Leucine or Phenylalanine Incorporation in Human Skeletal Muscle †
por: Mazzulla, Michael, et al.
Publicado: (2021)

Stabilization of a prokaryotic LAT transporter by random mutagenesis
por: Rodríguez-Banqueri, Arturo, et al.
Publicado: (2016)

Effect of mTOR inhibitors on sodium taurocholate cotransporting polypeptide (NTCP) function in vitro
por: Saran, Chitra, et al.
Publicado: (2023)

Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno‐foetal amino acid transport
por: Zaugg, Jonas, et al.
Publicado: (2020)

In silico Description of LAT1 Transport Mechanism at an Atomistic Level
por: Palazzolo, Luca, et al.
Publicado: (2018)

Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB(0,+), LAT1 and LAT2
por: Wongthai, Printip, et al.
Publicado: (2015)

Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors
por: Barollo, Susi, et al.
Publicado: (2016)

Machine Learning-Boosted Docking Enables the Efficient Structure-Based Virtual Screening of Giga-Scale Enumerated Chemical Libraries
por: Sivula, Toni, et al.
Publicado: (2023)

Whole grain intake associated molecule 5-aminovaleric acid betaine decreases β-oxidation of fatty acids in mouse cardiomyocytes
por: Kärkkäinen, Olli, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q8ul86h9348p5tu05apt0lm56d